Loading clinical trials...

Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout | Clinical Trials | Clareo Health

UNKNOWNNCT05522504

Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout

The purpose of this study is to evaluate whether immune cells and their subtypes in peripheral blood affects the asymptomatic hyperuricemia, gout flare, intercritical gout and advanced gout.

Lead sponsor: Ai Peng•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 4

Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares

NCT07346079 · Gout Arthritis, Gout Flare, and more

RECRUITINGPhase 1

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic of IBI3011

NCT07295496 · Acute Gout Flare

Not Yet RecruitingNA

Efficacy and Safety of Scheduled Versus As-Needed Firsekibart Administration for the Prevention of Gout Recurrence: A Multicenter, Open-Label, Randomized Controlled Trial

NCT07616531 · Gout Flares

WITHDRAWN

Serum Potassium Prediction Using Machine Learning and Single-lead ECG

NCT07493798 · Infection, Heart Failure, and more

WITHDRAWN

Prediction of Expected Length of Hospital Stay Using Machine Learning

NCT04784351 · Infection, Heart Failure, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 8, 2024Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment600

Start dateSep 2022

Last updatedMay 8, 2024

Condition

Gout Flare Intercritical Gout Advanced Gout Asymptomatic Hyperuricemia

Locations shown

Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital

Shanghai, Shanghai Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 8, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions